Drug class
Long-acting oxytocin-receptor agonist; uterotonic peptide analogue
Mechanism of action
Selectively binds oxytocin receptors in uterine smooth muscle, stimulates rhythmic contractions, increases the frequency of existing contractions and raises uterine tone. The effect is longer lasting than oxytocin.
General use cases
- Prevention of postpartum haemorrhage due to uterine atony following caesarean section or vaginal delivery; a single dose is administered only after delivery under specialist obstetric supervision. It must not be used to induce labour.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
